Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

CKD: A Call for an Age-Adapted Definition.

Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG.

J Am Soc Nephrol. 2019 Sep 10. pii: ASN.2019030238. doi: 10.1681/ASN.2019030238. [Epub ahead of print] Review.

PMID:
31506289
2.

Anticoagulant-Related Nephropathy: It's the Real McCoy.

Glassock RJ.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):935-937. doi: 10.2215/CJN.02470319. Epub 2019 May 21. No abstract available.

PMID:
31113769
3.

Mortality Risk in IgA Nephropathy.

Glassock RJ.

J Am Soc Nephrol. 2019 May;30(5):720-722. doi: 10.1681/ASN.2018121255. Epub 2019 Apr 10. No abstract available.

PMID:
31040186
4.

Prevention of complications from use of conventional immunosuppressants: a critical review.

Ponticelli C, Glassock RJ.

J Nephrol. 2019 Mar 29. doi: 10.1007/s40620-019-00602-5. [Epub ahead of print] Review.

PMID:
30927190
5.

Evaluation of living donors: quo vadis for GFR criteria?

Glassock RJ.

Kidney Int. 2019 Apr;95(4):738-740. doi: 10.1016/j.kint.2019.01.015.

PMID:
30904061
6.

Albuminuria: a target for clinical trials in kidney disease?

Glassock RJ.

Nat Rev Nephrol. 2019 May;15(5):257-258. doi: 10.1038/s41581-019-0123-x. No abstract available.

PMID:
30765852
7.

Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.

De Vriese AS, Sethi S, Nath KA, Glassock RJ, Fervenza FC.

J Am Soc Nephrol. 2018 Mar;29(3):759-774. doi: 10.1681/ASN.2017090958. Epub 2018 Jan 10.

8.

Donation, Not Disease! A Multiple-Hit Hypothesis on Development of Post-Donation Kidney Disease.

Cheng XS, Glassock RJ, Lentine KL, Chertow GM, Tan JC.

Curr Transplant Rep. 2017;4(4):320-326. doi: 10.1007/s40472-017-0171-8. Epub 2017 Nov 4. Review.

9.

Reply to Letter to the Editor.

Glassock RJ, Denic A, Rule AD.

J Bras Nefrol. 2017 Jul-Sep;39(3):347-348. doi: 10.5935/0101-2800.20170061. English, Portuguese. No abstract available.

10.

Data on the relation between renal biomarkers and measured glomerular filtration rate.

Pottel H, Dubourg L, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Bevc S, Delanaye P, Ebert N.

Data Brief. 2017 Sep 1;14:763-772. doi: 10.1016/j.dib.2017.08.034. eCollection 2017 Oct.

11.

Single-Nephron Glomerular Filtration Rate in Healthy Adults.

Denic A, Glassock RJ, Rule AD.

N Engl J Med. 2017 Sep 21;377(12):1203-4. doi: 10.1056/NEJMc1709128. No abstract available.

PMID:
28930503
12.

Structural and Functional Changes in Human Kidneys with Healthy Aging.

Hommos MS, Glassock RJ, Rule AD.

J Am Soc Nephrol. 2017 Oct;28(10):2838-2844. doi: 10.1681/ASN.2017040421. Epub 2017 Aug 8. Review.

13.

Epidemiology of chronic kidney disease: think (at least) twice!

Delanaye P, Glassock RJ, De Broe ME.

Clin Kidney J. 2017 Jun;10(3):370-374. doi: 10.1093/ckj/sfw154. Epub 2017 Feb 27.

14.

Single-Nephron Glomerular Filtration Rate in Healthy Adults.

Denic A, Mathew J, Lerman LO, Lieske JC, Larson JJ, Alexander MP, Poggio E, Glassock RJ, Rule AD.

N Engl J Med. 2017 Jun 15;376(24):2349-2357. doi: 10.1056/NEJMoa1614329.

15.

Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.

Musso CG, Juarez R, Glassock RJ.

Int Urol Nephrol. 2018 Jan;50(1):81-89. doi: 10.1007/s11255-017-1614-y. Epub 2017 Jun 12. Review.

PMID:
28608260
16.

The diagnostic value of rescaled renal biomarkers serum creatinine and serum cystatin C and their relation with measured glomerular filtration rate.

Pottel H, Dubourg L, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Bevc S, Delanaye P, Ebert N.

Clin Chim Acta. 2017 Aug;471:164-170. doi: 10.1016/j.cca.2017.06.005. Epub 2017 Jun 7.

17.

Glomerular disease: Targeted steroid therapy for IgA nephropathy.

Glassock RJ.

Nat Rev Nephrol. 2017 Jul;13(7):390-392. doi: 10.1038/nrneph.2017.65. Epub 2017 May 22. No abstract available.

PMID:
28529338
18.

What are we missing in the clinical trials of focal segmental glomerulosclerosis?

Zand L, Glassock RJ, De Vriese AS, Sethi S, Fervenza FC.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i14-i21. doi: 10.1093/ndt/gfw324. Review.

PMID:
28391338
19.

Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality.

Glassock RJ, Rule AD.

Nephrol Dial Transplant. 2017 Apr 1;32(4):585-587. doi: 10.1093/ndt/gfx007. No abstract available.

20.

A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Sethi S, D'Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, Glassock RJ, Fervenza FC, Seshan SV, Rule A, Racusen LC, Radhakrishnan J, Winearls CG, Appel GB, Bajema IM, Chang A, Colvin RB, Cook HT, Hariharan S, Herrera Hernandez LP, Kambham N, Mengel M, Nath KA, Rennke HG, Ronco P, Rovin BH, Haas M.

Kidney Int. 2017 Apr;91(4):787-789. doi: 10.1016/j.kint.2017.01.002.

PMID:
28314581
21.

Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria.

Warnock DG, Delanaye P, Glassock RJ.

Nephron. 2017;136(4):292-297. doi: 10.1159/000455197. Epub 2017 Jan 27. Review.

22.

Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.

Pottel H, Delanaye P, Schaeffner E, Dubourg L, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Ebert N.

Nephrol Dial Transplant. 2017 Mar 1;32(3):497-507. doi: 10.1093/ndt/gfw425.

23.

The global burden of chronic kidney disease: estimates, variability and pitfalls.

Glassock RJ, Warnock DG, Delanaye P.

Nat Rev Nephrol. 2017 Feb;13(2):104-114. doi: 10.1038/nrneph.2016.163. Epub 2016 Dec 12. Review.

24.

The conundrums of chronic kidney disease and aging.

Glassock RJ, Denic A, Rule AD.

J Nephrol. 2017 Aug;30(4):477-483. doi: 10.1007/s40620-016-0362-x. Epub 2016 Nov 25. Review.

PMID:
27885585
25.

Moderator's view: Treatment of IgA nephropathy-getting comfortable with uncertainty.

Glassock RJ.

Nephrol Dial Transplant. 2016 Nov;31(11):1776-1780. Epub 2016 Aug 11.

PMID:
27515695
26.

A Proposal for a Serology-Based Approach to Membranous Nephropathy.

De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC.

J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24. Review.

27.

Evaluation of proteinuria redux.

Glassock RJ.

Kidney Int. 2016 Nov;90(5):938-940. doi: 10.1016/j.kint.2016.07.044.

PMID:
27742197
28.

Atypical anti-glomerular basement membrane disease: lessons learned.

Glassock RJ.

Clin Kidney J. 2016 Oct;9(5):653-6. doi: 10.1093/ckj/sfw068. Epub 2016 Jul 28.

29.

Urinary Chemoattractant Protein 1: A New Biomarker of Renal Fibrosis.

Glassock RJ.

Am J Nephrol. 2016;43(6):451-3. doi: 10.1159/000446864. Epub 2016 Jun 10. No abstract available.

30.

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Delanaye P, Glassock RJ.

N Engl J Med. 2016 May 26;374(21):2093-4. doi: 10.1056/NEJMc1603007. No abstract available.

31.

IgA nephropathy.

Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ.

Nat Rev Dis Primers. 2016 Feb 11;2:16001. doi: 10.1038/nrdp.2016.1. Review.

PMID:
27189177
32.

An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.

Delanaye P, Glassock RJ, Pottel H, Rule AD.

Clin Biochem Rev. 2016 Feb;37(1):17-26.

33.

Aging and the Kidneys: Anatomy, Physiology and Consequences for Defining Chronic Kidney Disease.

Glassock RJ, Rule AD.

Nephron. 2016;134(1):25-9. doi: 10.1159/000445450. Epub 2016 Apr 7. Review.

34.

An estimated glomerular filtration rate equation for the full age spectrum.

Pottel H, Hoste L, Dubourg L, Ebert N, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Mariat C, Martens F, Delanaye P.

Nephrol Dial Transplant. 2016 May;31(5):798-806. doi: 10.1093/ndt/gfv454. Epub 2016 Feb 29.

35.

Control of albuminuria in overt diabetic nephropathy: durability counts.

Glassock RJ.

Nephrol Dial Transplant. 2016 Sep;31(9):1371-3. doi: 10.1093/ndt/gfv462. Epub 2016 Feb 6. No abstract available.

PMID:
26908761
36.

Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Musso CG, Belloso WH, Glassock RJ.

World J Nephrol. 2016 Jan 6;5(1):33-42. doi: 10.5527/wjn.v5.i1.33. Review.

37.

Managing Chronic Kidney Disease in Older People--Reply.

Glassock RJ, Delanaye P, El-Nahas M.

JAMA. 2016 Jan 19;315(3):307-8. doi: 10.1001/jama.2015.15999. No abstract available.

38.

Structural and Functional Changes With the Aging Kidney.

Denic A, Glassock RJ, Rule AD.

Adv Chronic Kidney Dis. 2016 Jan;23(1):19-28. doi: 10.1053/j.ackd.2015.08.004. Review.

39.

Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC.

J Am Soc Nephrol. 2016 May;27(5):1278-87. doi: 10.1681/ASN.2015060612. Epub 2015 Nov 13.

40.

In reply--New Oral Anticoagulants in Elderly Adults With Chronic Kidney Disease.

Ponticelli C, Glassock RJ.

Mayo Clin Proc. 2015 Nov;90(11):1589-90. doi: 10.1016/j.mayocp.2015.09.003. No abstract available.

PMID:
26541257
41.

In Reply to 'Expanding the Domain of Postinfectious Glomerulonephritis' and 'Postinfectious Versus Infection-Related Glomerulonephritis'.

Hebert LA, Glassock RJ.

Am J Kidney Dis. 2015 Oct;66(4):726. doi: 10.1053/j.ajkd.2015.07.016. No abstract available.

PMID:
26408238
42.

Glomerular Filtration Rate and Aging: Another Longitudinal Study--A Long Time Coming!

Delanaye P, Glassock RJ.

Nephron. 2015;131(1):1-4. doi: 10.1159/000439147. Epub 2015 Aug 21. No abstract available.

43.

Lifetime Risk of CKD: What Does It Really Mean?

Delanaye P, Glassock RJ.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1504-6. doi: 10.2215/CJN.07860715. Epub 2015 Aug 18. No abstract available.

44.

The myth of the future burden of CKD in United States.

Delanaye P, El Nahas M, Glassock RJ.

Am J Kidney Dis. 2015 Jul;66(1):171-2. doi: 10.1053/j.ajkd.2015.01.035. No abstract available.

45.

Safety of living kidney donation: another brick in the wall…and a solid (physiologic) one.

Delanaye P, Mariat C, Glassock RJ.

Am J Kidney Dis. 2015 Jul;66(1):1-3. doi: 10.1053/j.ajkd.2015.04.005. No abstract available.

46.

Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining "post" is important in understanding and treating infection-related glomerulonephritis.

Glassock RJ, Alvarado A, Prosek J, Hebert C, Parikh S, Satoskar A, Nadasdy T, Forman J, Rovin B, Hebert LA.

Am J Kidney Dis. 2015 Jun;65(6):826-32. doi: 10.1053/j.ajkd.2015.01.023. Epub 2015 Apr 15.

PMID:
25890425
47.

Hypertension: Impact of blood pressure lowering in type 2 diabetes.

Glassock RJ, Bakris GL.

Nat Rev Nephrol. 2015 Jun;11(6):320-1. doi: 10.1038/nrneph.2015.48. Epub 2015 Apr 7. No abstract available.

PMID:
25848880
48.

Opponent's comments.

Glassock RJ.

Nephrol Dial Transplant. 2015 Apr;30(4):537-8. doi: 10.1093/ndt/gfv046a. No abstract available.

PMID:
25801639
49.

Con: kidney biopsy: an irreplaceable tool for patient management in nephrology.

Glassock RJ.

Nephrol Dial Transplant. 2015 Apr;30(4):528-31. doi: 10.1093/ndt/gfv044. No abstract available.

PMID:
25801636
50.

Drug management in the elderly adult with chronic kidney disease: a review for the primary care physician.

Ponticelli C, Sala G, Glassock RJ.

Mayo Clin Proc. 2015 May;90(5):633-45. doi: 10.1016/j.mayocp.2015.01.016. Epub 2015 Mar 12. Review.

PMID:
25771152

Supplemental Content

Loading ...
Support Center